Search
-
News
Study will be the first clinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s disease (PD).
… Friday, January 15, 2021 A recent approval from the U.S. Food and Drug Administration will allow MSK researchers and their collaborators to open the firstclinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s
-
News
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
… Tuesday, June 21, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Alban Ordureau Selected into the 2022 Class of Pew Scholars in Biomedical Sciences Alban Ordureau, PhD Alban Ordureau, PhD , has been selected into the 2022 class of Pew Scholars in Biomedical
-
News
Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
… Tuesday, December 1, 2009 Summary Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors. Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be
-
News
People with prostate cancer can benefit from exercise in more ways than they might expect.
… Thursday, September 24, 2020 Summary Treatments for prostate cancer can cause side effects such as loss of muscle mass and fatigue. Finding the time and energy to exercise is difficult for many people. For men diagnosed with prostate cancer, it can be especially challenging because treatments often
-
MSK News
Learn how Dr. Chrysothemis Brown is shedding light on new types of immune cells and their role in cancer and other diseases.
… Tuesday, November 7, 2023 When physician-scientist Chrysothemis Brown, MBBS, PhD , talks about the process of scientific discovery and the nuances of the immune system, the sincerity of her enthusiasm is unmistakable. “What I love about science is the freedom and creativity,” Dr. Brown says. “And if
-
News
Meet Sheree Scarlett, who helps to promote the wellness-related resources available to employees in her role in Employee Health and Wellness Services at MSK.
… Tuesday, February 1, 2022 In her role in Employee Health and Wellness Services at Memorial Sloan Kettering Cancer Center, Sheree Scarlett helps to promote the wellness-related resources available to employees, including the recently launched Guided Wellbeing program. Sheree was born in Kingston, Jamaica
-
News
Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer.
… Wednesday, December 10, 2025 People with hormone receptor (HR)-positive, HER2-negative breast cancer that has spread (metastasized) usually receive endocrine therapy as the first treatment. These breast cancers often ultimately become resistant to endocrine therapy and continue growing. At this point
-
News
Cancer treatments like chemotherapy may cause cognitive changes, which experts call “chemo brain.” Learn how Memorial Sloan Kettering experts help patients with this condition.
… Tuesday, May 3, 2016 Summary Patients undergoing chemotherapy sometimes experience “chemo brain,” a frustrating ailment marked by cognitive changes that can sometimes mimic other conditions. MSK offers help from occupational therapists like Grace Chen , who help patients experiencing chemo brain to
-
News
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
… Friday, December 2, 2016 Summary The association between alcohol and cancer risk is well known. But a new study attempts to draw a direct tie between drinking alcohol and developing melanoma. Two MSK experts weigh in on the findings. Highlights A new analysis found that alcohol intake was associated
-
News
… Wednesday, October 1, 2008 October 2008 - The school welcomes five new faculty members. Julia Kaltschmidt Developmental Biology Research Interests: Understanding the mechanisms of synaptic specificity underlying neuronal circuit formation. Minkui Luo Molecular Pharmacology and Chemistry Research Interests